Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-01-15

AUTHORS

Chase S. Correia, Melissa R. Briones, Rong Guo, Rochella A. Ostrowski

ABSTRACT

This paper is to examine the relationship between anti-cyclic citrullinated peptide (anti-CCP) antibody titers and the development of interstitial lung disease (ILD) in patients with and without rheumatoid arthritis (RA). A retrospective investigation was conducted on all adult patients tested for anti-CCP between January 1, 2007, and December 31, 2012, in a university healthcare system. Patients with specified exposures or conditions known to cause ILD were excluded. The prevalence of ILD was compared between those with and without a positive CCP. The study population was then divided into four titer groups based on anti-CCP titers: negative, low titer, moderate titer, high titer. Fisher’s exact tests compared the prevalence of ILD among the anti-CCP titer groups. Multivariate logistic regression examined the association between anti-CCP and ILD while controlling for confounders. These analyses were repeated in two subgroups: a “confirmed RA” subgroup and an “unconfirmed RA” subgroup. Two thousand and thirty patients met inclusion criteria and 453 of those had confirmed RA. Progressively higher anti-CCP titer groups developed an increasingly higher prevalence of ILD (p < 0.01). When adjusting for age, tobacco, and a diagnosis of RA, higher anti-CCP titer groups continued to correlate with an increased prevalence of ILD (OR 1.47, 95% CI 1.10–1.96, p < 0.001). This study is the first to show that progressively higher anti-CCP titers correlate with increasing prevalence of ILD, even when adjusting for confounders. More... »

PAGES

1201-1206

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10067-018-04421-0

DOI

http://dx.doi.org/10.1007/s10067-018-04421-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111431338

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30645754


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Citrullinated Protein Antibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Diseases, Interstitial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Rheumatology, Northwestern Memorial Hospital, 675 North Saint Clair Street, 14th Floor Suite 100, 60611, Chicago, IL, USA", 
          "id": "http://www.grid.ac/institutes/grid.416565.5", 
          "name": [
            "Division of Rheumatology, Northwestern Memorial Hospital, 675 North Saint Clair Street, 14th Floor Suite 100, 60611, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Correia", 
        "givenName": "Chase S.", 
        "id": "sg:person.014753072723.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014753072723.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA", 
          "id": "http://www.grid.ac/institutes/grid.411451.4", 
          "name": [
            "Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Briones", 
        "givenName": "Melissa R.", 
        "id": "sg:person.010710573113.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010710573113.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine Statistics Core, University of California, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Department of Medicine Statistics Core, University of California, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guo", 
        "givenName": "Rong", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA", 
          "id": "http://www.grid.ac/institutes/grid.411451.4", 
          "name": [
            "Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ostrowski", 
        "givenName": "Rochella A.", 
        "id": "sg:person.01070402624.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070402624.85"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-3-642-28753-4_201937", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002203233", 
          "https://doi.org/10.1007/978-3-642-28753-4_201937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12026-013-8395-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004035819", 
          "https://doi.org/10.1007/s12026-013-8395-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10067-007-0800-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025478929", 
          "https://doi.org/10.1007/s10067-007-0800-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-01-15", 
    "datePublishedReg": "2019-01-15", 
    "description": "This paper is to examine the relationship between anti-cyclic citrullinated peptide (anti-CCP) antibody titers and the development of interstitial lung disease (ILD) in patients with and without rheumatoid arthritis (RA). A retrospective investigation was conducted on all adult patients tested for anti-CCP between January 1, 2007, and December 31, 2012, in a university healthcare system. Patients with specified exposures or conditions known to cause ILD were excluded. The prevalence of ILD was compared between those with and without a positive CCP. The study population was then divided into four titer groups based on anti-CCP titers: negative, low titer, moderate titer, high titer. Fisher\u2019s exact tests compared the prevalence of ILD among the anti-CCP titer groups. Multivariate logistic regression examined the association between anti-CCP and ILD while controlling for confounders. These analyses were repeated in two subgroups: a \u201cconfirmed RA\u201d subgroup and an \u201cunconfirmed RA\u201d subgroup. Two thousand and thirty patients met inclusion criteria and 453 of those had confirmed RA. Progressively higher anti-CCP titer groups developed an increasingly higher prevalence of ILD (p\u2009<\u20090.01). When adjusting for age, tobacco, and a diagnosis of RA, higher anti-CCP titer groups continued to correlate with an increased prevalence of ILD (OR 1.47, 95% CI 1.10\u20131.96, p\u2009<\u20090.001). This study is the first to show that progressively higher anti-CCP titers correlate with increasing prevalence of ILD, even when adjusting for confounders.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10067-018-04421-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7072407", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1093299", 
        "issn": [
          "0770-3198", 
          "1434-9949"
        ], 
        "name": "Clinical Rheumatology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "38"
      }
    ], 
    "keywords": [
      "prevalence of ILD", 
      "interstitial lung disease", 
      "peptide antibody titer", 
      "rheumatoid arthritis", 
      "anti-CCP titers", 
      "titer group", 
      "lung disease", 
      "antibody titers", 
      "exact test", 
      "diagnosis of RA", 
      "multivariate logistic regression", 
      "university healthcare system", 
      "Fisher's exact test", 
      "adult patients", 
      "Anti-CCP", 
      "moderate titers", 
      "inclusion criteria", 
      "high prevalence", 
      "study population", 
      "retrospective investigation", 
      "patients", 
      "low titers", 
      "high titers", 
      "logistic regression", 
      "prevalence", 
      "titers", 
      "healthcare system", 
      "confounders", 
      "subgroups", 
      "disease", 
      "group", 
      "arthritis", 
      "diagnosis", 
      "age", 
      "risk", 
      "CCP", 
      "exposure", 
      "association", 
      "regression", 
      "tobacco", 
      "population", 
      "criteria", 
      "study", 
      "test", 
      "development", 
      "relationship", 
      "investigation", 
      "analysis", 
      "conditions", 
      "system", 
      "paper", 
      "positive CCP", 
      "CCP titer groups", 
      "unconfirmed RA", 
      "higher anti-CCP titer groups", 
      "anti-CCP titer groups", 
      "higher anti-CCP titers"
    ], 
    "name": "Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease", 
    "pagination": "1201-1206", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111431338"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10067-018-04421-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30645754"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10067-018-04421-0", 
      "https://app.dimensions.ai/details/publication/pub.1111431338"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_827.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10067-018-04421-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10067-018-04421-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10067-018-04421-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10067-018-04421-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10067-018-04421-0'


 

This table displays all metadata directly associated to this object as RDF triples.

195 TRIPLES      22 PREDICATES      95 URIs      84 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10067-018-04421-0 schema:about N006bc989e88044b5bba0851aa1468277
2 N067090357ea448e9b6d223ecd72e6bca
3 N0c36dd82984a48ee8704580629e5b250
4 N0db46a6720c946b88eeef7dbac5e7f6f
5 N4a98a45d070a40b9801cc2121a49364e
6 N78e819fb3a494e6989249a974a3de6cd
7 N7c5c404297dd4ad4824bbb8e16aec449
8 Nace347f61ccb41daafdd7f411510ae47
9 Nc5ab445fb6704fdb9447d6c980353c29
10 anzsrc-for:11
11 anzsrc-for:1103
12 schema:author N2b8fb33ed402428cb369faf4acb19da5
13 schema:citation sg:pub.10.1007/978-3-642-28753-4_201937
14 sg:pub.10.1007/s10067-007-0800-1
15 sg:pub.10.1007/s12026-013-8395-x
16 schema:datePublished 2019-01-15
17 schema:datePublishedReg 2019-01-15
18 schema:description This paper is to examine the relationship between anti-cyclic citrullinated peptide (anti-CCP) antibody titers and the development of interstitial lung disease (ILD) in patients with and without rheumatoid arthritis (RA). A retrospective investigation was conducted on all adult patients tested for anti-CCP between January 1, 2007, and December 31, 2012, in a university healthcare system. Patients with specified exposures or conditions known to cause ILD were excluded. The prevalence of ILD was compared between those with and without a positive CCP. The study population was then divided into four titer groups based on anti-CCP titers: negative, low titer, moderate titer, high titer. Fisher’s exact tests compared the prevalence of ILD among the anti-CCP titer groups. Multivariate logistic regression examined the association between anti-CCP and ILD while controlling for confounders. These analyses were repeated in two subgroups: a “confirmed RA” subgroup and an “unconfirmed RA” subgroup. Two thousand and thirty patients met inclusion criteria and 453 of those had confirmed RA. Progressively higher anti-CCP titer groups developed an increasingly higher prevalence of ILD (p < 0.01). When adjusting for age, tobacco, and a diagnosis of RA, higher anti-CCP titer groups continued to correlate with an increased prevalence of ILD (OR 1.47, 95% CI 1.10–1.96, p < 0.001). This study is the first to show that progressively higher anti-CCP titers correlate with increasing prevalence of ILD, even when adjusting for confounders.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree true
22 schema:isPartOf Nabf18a6a0cf343c88acec44f744a1df9
23 Ne68526555df74111aabcc1e51ffc08a7
24 sg:journal.1093299
25 schema:keywords Anti-CCP
26 CCP
27 CCP titer groups
28 Fisher's exact test
29 adult patients
30 age
31 analysis
32 anti-CCP titer groups
33 anti-CCP titers
34 antibody titers
35 arthritis
36 association
37 conditions
38 confounders
39 criteria
40 development
41 diagnosis
42 diagnosis of RA
43 disease
44 exact test
45 exposure
46 group
47 healthcare system
48 high prevalence
49 high titers
50 higher anti-CCP titer groups
51 higher anti-CCP titers
52 inclusion criteria
53 interstitial lung disease
54 investigation
55 logistic regression
56 low titers
57 lung disease
58 moderate titers
59 multivariate logistic regression
60 paper
61 patients
62 peptide antibody titer
63 population
64 positive CCP
65 prevalence
66 prevalence of ILD
67 regression
68 relationship
69 retrospective investigation
70 rheumatoid arthritis
71 risk
72 study
73 study population
74 subgroups
75 system
76 test
77 titer group
78 titers
79 tobacco
80 unconfirmed RA
81 university healthcare system
82 schema:name Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease
83 schema:pagination 1201-1206
84 schema:productId N2a82b9e8391c413a98d14951c9cb33a5
85 N48a1b9e1c9bc4e02851e1e72ef695f48
86 Nf170ae1ba2e94944a043aca8177a1764
87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111431338
88 https://doi.org/10.1007/s10067-018-04421-0
89 schema:sdDatePublished 2022-01-01T18:55
90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
91 schema:sdPublisher N7906db854ace42059c01bb2e079fe60c
92 schema:url https://doi.org/10.1007/s10067-018-04421-0
93 sgo:license sg:explorer/license/
94 sgo:sdDataset articles
95 rdf:type schema:ScholarlyArticle
96 N006bc989e88044b5bba0851aa1468277 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Anti-Citrullinated Protein Antibodies
98 rdf:type schema:DefinedTerm
99 N067090357ea448e9b6d223ecd72e6bca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Retrospective Studies
101 rdf:type schema:DefinedTerm
102 N0c36dd82984a48ee8704580629e5b250 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Biomarkers
104 rdf:type schema:DefinedTerm
105 N0db46a6720c946b88eeef7dbac5e7f6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Female
107 rdf:type schema:DefinedTerm
108 N2a82b9e8391c413a98d14951c9cb33a5 schema:name pubmed_id
109 schema:value 30645754
110 rdf:type schema:PropertyValue
111 N2b8fb33ed402428cb369faf4acb19da5 rdf:first sg:person.014753072723.68
112 rdf:rest Nf8e46f93981b4390adbc08c0646bf962
113 N48a1b9e1c9bc4e02851e1e72ef695f48 schema:name doi
114 schema:value 10.1007/s10067-018-04421-0
115 rdf:type schema:PropertyValue
116 N4a98a45d070a40b9801cc2121a49364e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Male
118 rdf:type schema:DefinedTerm
119 N6fea4dcd06b84289afb9239618661968 schema:affiliation grid-institutes:grid.19006.3e
120 schema:familyName Guo
121 schema:givenName Rong
122 rdf:type schema:Person
123 N78e819fb3a494e6989249a974a3de6cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Lung Diseases, Interstitial
125 rdf:type schema:DefinedTerm
126 N7906db854ace42059c01bb2e079fe60c schema:name Springer Nature - SN SciGraph project
127 rdf:type schema:Organization
128 N7c5c404297dd4ad4824bbb8e16aec449 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Middle Aged
130 rdf:type schema:DefinedTerm
131 Nabf18a6a0cf343c88acec44f744a1df9 schema:volumeNumber 38
132 rdf:type schema:PublicationVolume
133 Nace347f61ccb41daafdd7f411510ae47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Risk Factors
135 rdf:type schema:DefinedTerm
136 Nc5ab445fb6704fdb9447d6c980353c29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Humans
138 rdf:type schema:DefinedTerm
139 Ne68526555df74111aabcc1e51ffc08a7 schema:issueNumber 4
140 rdf:type schema:PublicationIssue
141 Nee636cc8af724b17b25ad86591104ebb rdf:first N6fea4dcd06b84289afb9239618661968
142 rdf:rest Nfb807034e051423fbad113ac660e7746
143 Nf170ae1ba2e94944a043aca8177a1764 schema:name dimensions_id
144 schema:value pub.1111431338
145 rdf:type schema:PropertyValue
146 Nf8e46f93981b4390adbc08c0646bf962 rdf:first sg:person.010710573113.64
147 rdf:rest Nee636cc8af724b17b25ad86591104ebb
148 Nfb807034e051423fbad113ac660e7746 rdf:first sg:person.01070402624.85
149 rdf:rest rdf:nil
150 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
151 schema:name Medical and Health Sciences
152 rdf:type schema:DefinedTerm
153 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
154 schema:name Clinical Sciences
155 rdf:type schema:DefinedTerm
156 sg:grant.7072407 http://pending.schema.org/fundedItem sg:pub.10.1007/s10067-018-04421-0
157 rdf:type schema:MonetaryGrant
158 sg:journal.1093299 schema:issn 0770-3198
159 1434-9949
160 schema:name Clinical Rheumatology
161 schema:publisher Springer Nature
162 rdf:type schema:Periodical
163 sg:person.01070402624.85 schema:affiliation grid-institutes:grid.411451.4
164 schema:familyName Ostrowski
165 schema:givenName Rochella A.
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070402624.85
167 rdf:type schema:Person
168 sg:person.010710573113.64 schema:affiliation grid-institutes:grid.411451.4
169 schema:familyName Briones
170 schema:givenName Melissa R.
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010710573113.64
172 rdf:type schema:Person
173 sg:person.014753072723.68 schema:affiliation grid-institutes:grid.416565.5
174 schema:familyName Correia
175 schema:givenName Chase S.
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014753072723.68
177 rdf:type schema:Person
178 sg:pub.10.1007/978-3-642-28753-4_201937 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002203233
179 https://doi.org/10.1007/978-3-642-28753-4_201937
180 rdf:type schema:CreativeWork
181 sg:pub.10.1007/s10067-007-0800-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025478929
182 https://doi.org/10.1007/s10067-007-0800-1
183 rdf:type schema:CreativeWork
184 sg:pub.10.1007/s12026-013-8395-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1004035819
185 https://doi.org/10.1007/s12026-013-8395-x
186 rdf:type schema:CreativeWork
187 grid-institutes:grid.19006.3e schema:alternateName Department of Medicine Statistics Core, University of California, Los Angeles, CA, USA
188 schema:name Department of Medicine Statistics Core, University of California, Los Angeles, CA, USA
189 rdf:type schema:Organization
190 grid-institutes:grid.411451.4 schema:alternateName Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA
191 schema:name Division of Allergy, Immunology, and Rheumatology, Loyola University Medical Center, Maywood, IL, USA
192 rdf:type schema:Organization
193 grid-institutes:grid.416565.5 schema:alternateName Division of Rheumatology, Northwestern Memorial Hospital, 675 North Saint Clair Street, 14th Floor Suite 100, 60611, Chicago, IL, USA
194 schema:name Division of Rheumatology, Northwestern Memorial Hospital, 675 North Saint Clair Street, 14th Floor Suite 100, 60611, Chicago, IL, USA
195 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...